Profile: BrainCells Inc. is a biopharmaceutical company that focuses on the development of breakthrough small molecule therapeutics for diseases of the central nervous system. We develop neurogenesis technology platform to identify clinical-stage compounds, novel targets and compounds optimal for CNS indications. We develop a pipeline of clinical-stage programs to address unmet medical needs in the treatment of mood disorders, psychoses, cognition, brain repair syndromes and other CNS disorders. We develop & deliver BCI-540 for the treatment of major depressive disorder combined with anxiety.